Regulation of bone mass by growth hormone

Medical and Pediatric Oncology

Volumn 41, Issue 3, 2003, Pages 228-234

  Olney, Robert C ^a  

^a NEMOURS CHILDREN S CLINIC   (United States)

Author keywords

Bone mineral density; Dual energy X ray absorptiometry; Growth hormone; Growth plate; Insulin like growth factor 1; Osteoblasts; Osteoclasts

Indexed keywords

GROWTH HORMONE; SOMATOMEDIN C;

BONE DENSITY; BONE GROWTH; BONE MASS; BONE METABOLISM; BONE REMODELING; CARTILAGE CELL; CELL DIFFERENTIATION; CELL PROLIFERATION; CONFERENCE PAPER; DUAL ENERGY X RAY ABSORPTIOMETRY; EPIPHYSIS PLATE; GROWTH PLATE; GROWTH REGULATION; HORMONAL REGULATION; HORMONE ACTION; HUMAN; OSSIFICATION; OSTEOBLAST; OSTEOCLAST; OSTEOLYSIS; PRIORITY JOURNAL;

ANIMALS; BONE DENSITY; BONE DEVELOPMENT; FRACTURE HEALING; HUMAN GROWTH HORMONE; HUMANS; INSULIN-LIKE GROWTH FACTOR I;

EID: 0042844486     PISSN: 00981532     EISSN: None     Source Type: Journal    
DOI: 10.1002/mpo.10342     Document Type: Conference Paper

References (50)

1. Svensson J, Lall S, Dickson SL, et al. Effects of growth hormone and its secretagogues on bone. Endocrine 2001;14(1):63-66.
2. Ohlsson C, Jansson JO, Isaksson O. Effects of growth hormone and insulin-like growth factor-I on body growth and adult bone metabolism. Curr Opin Rheumatol 2000;12(4):346-348.
3. Soyka LA, Fairfield WP, Klibanski A. Clinical review 117: Hormonal determinants and disorders of peak bone mass in children. J Clin Endocrinol Metab 2000;85(11):3951-3963.
4. Isaksson OG, Ohlsson C, Bengtsson BA, et al. GH and bone Experimental and clinical studies. Endocr J 2000;47(Suppl):S9-S16.
5. Ohlsson C, Bengtsson BA, Isaksson OG, et al. Growth hormone and bone. Endocr Rev 1998;19(1):55-79.
6. Veldhuis JD, Anderson SM, Shah N, et al. Neurophysiological regulation and target-tissue impact of the pulsatile mode of growth hormone secretion in the human. Growth Horm IGF Res 2001;11(Suppl A):S25-S37.
7. Penalva A, Baldelli R, Camina JP, et al. Physiology and possible pathology of growth hormone secretagogues. J Pediatr Endocrinol Metab 2001;14(Suppl 5):1207-1212.
8. Spagnoli A, Rosenfeld RG. The mechanisms by which growth hormone brings about growth. The relative contributions of growth hormone and insulin-like growth factors. Endocrinol Metab Clin North Am 1996;25(3):615-631.
9. Jones JI, Clemmons DR. Insulin-like growth factors and their binding proteins: Biological actions. Endocr Rev 1995;16:3-34.
10. Diamond FB, Jr., Bercu BB. Endocrine sequelae of cancer therapy in childhood. J Endocrinol Invest 2001;24(9):648-658.
11. Johansson AG, Burman P, Westermark K, et al. The bone mineral density in acquired growth hormone deficiency correlates with circulating levels of insulin-like growth factor I. J Intern Med 1992;232(5):447-452.
12. Bing-You RG, Denis MC, Rosen CJ. Low bone mineral density in adults with previous hypothalamic-pituitary tumors: Correlations with serum growth hormone responses to GH-releasing hormone, insulin-like growth factor I, and IGF binding protein 3. Calcif Tissue Int 1993;52(3):183-187.
13. Rosen T, Hansson T, Granhed H, et al. Reduced bone mineral content in adult patients with growth hormone deficiency. Acta Endocrinol (Copenh) 1993;129(3):201-206.
14. Holmes SJ, Economou G, Whitehouse RW, et al. Reduced bone mineral density in patients with adult onset growth hormone deficiency. J Clin Endocrinol Metab 1994;78(3):669-674.
15. Toogood AA, Adams JE, O'Neill PA, et al. Elderly patients with adult-onset growth hormone deficiency are not osteopenic. J Clin Endocrinol Metab 1997;82(5):1462-1466.
16. Rosen T, Wilhelmsen L, Landin-Wilhelmsen K, et al. Increased fracture frequency in adult patients with hypopituitarism and GH deficiency. Eur J Endocrinol 1997;137(3):240-245.
17. Wuster C. Fracture rates in patients with growth hormone deficiency. Horm Res 2000;54(Suppl 1):31-35.
18. Fernholm R, Bramnert M, Hagg E, et al. Growth hormone replacement therapy improves body composition and increases bone metabolism in elderly patients with pituitary disease. J Clin Endocrinol Metab 2000;85(11):4104-4112.
19. Beshyah SA, Kyd P, Thomas E, et al. The effects of prolonged growth hormone replacement on bone metabolism and bone mineral density in hypopituitary adults. Clin Endocrinol (Oxf) 1995;42(3):249-254.
20. Beshyah SA, Thomas E, Kyd P, et al. The effect of growth hormone replacement therapy in hypopituitary adults on calcium and bone metabolism. Clin Endocrinol (Oxf) 1994;40(3):383-391.
21. Holmes SJ, Whitehouse RW, Swindell R, et al. Effect of growth hormone replacement on bone mass in adults with adult onset growth hormone deficiency. Clin Endocrinol (Oxf) 1995;42(6): 627-633.
22. Degerblad M, Bengtsson BA, Bramnert M, et al. Reduced bone mineral density in adults with growth hormone (GH) deficiency: Increased bone turnover during 12 months of GH substitution therapy. Eur J Endocrinol 1995;133(2):180-188.
23. Johannsson G, Rosen T, Bosaeus I, et al. Two years of growth hormone (GH) treatment increases bone mineral content and density in hypopituitary patients with adult-onset GH deficiency. J Clin Endocrinol Metab 1996;81(8):2865-2873.
24. Clanget C, Seck T, Hinke V, et al. Effects of 6 years of growth hormone (GH) treatment on bone mineral density in GH-deficient adults. Clin Endocrinol (Oxf) 2001;55(1):93-99.
25. Holmes SJ, Whitehouse RW, Economou G, et al. Further increase in forearm cortical bone mineral content after discontinuation of growth hormone replacement. Clin Endocrinol (Oxf) 1995;42(1): 3-7.
26. Kassem M, Blum W, Ristelli J, et al. Growth hormone stimulates proliferation and differentiation of normal human osteoblast-like cells in vitro. Calcif Tissue Int 1993;52(3):222-226.
27. Scheven BA, Hamilton NJ, Fakkeldij TM, et al. Effects of recombinant human insulin-like growth factor I and II (IGF-I/-II) and growth hormone (GH) on the growth of normal adult human osteoblast-like cells and human osteogenic sarcoma cells. Growth Regul 1991;1(4):160-167.
28. Kassem M, Mosekilde L, Eriksen EF. Growth hormone stimulates proliferation of normal human bone marrow stromal osteoblast precursor cells in vitro. Growth Regul 1994;4(3):131-135.
29. 3 and activity on human osteoblast-like cells in short-term cultures. Bone 1990;11(2):81-86.
30. Hock JM, Centrella M, Canalis E. Insulin-like growth factor I has independent effects on bone matrix formation and cell replication. Endocrinology 1988;122(1):254-260.
31. Langdahl BL, Kassem M, Moller MK, et al. The effects of IGF-I and IGF-II on proliferation and differentiation of human osteoblasts and interactions with growth hormone. Eur J Clin Invest 1998;28(3):176-183.
32. Okazaki R, Conover CA, Harris SA, et al. Normal human osteoblast-like cells consistently express genes for insulin-like growth factors I and II but transformed human osteoblast cell lines do not. J Bone Miner Res 1995;10(5):788-795.
33. Schneider MR, Wolf E, Hoeflich A, et al. IGF-binding protein-5: Flexible player in the IGF system and effector on its own. J Endocrinol 2002;172(3):423-440.
34. Leung KC, Waters MJ, Markus I, et al. Insulin and insulin-like growth factor-I acutely inhibit surface translocation of growth hormone receptors in osteoblasts: A novel mechanism of growth hormone receptor regulation. Proc Natl Acad Sci USA 1997;94(21):11381-11386.
35. Leung K, Rajkovic IA, Peters E, et al. Insulin-like growth factor I and insulin down-regulate growth hormone (GH) receptors in rat osteoblasts: Evidence for a peripheral feedback loop regulating GH action. Endocrinology 1996;137(7):2694-2702.
36. Nishiyama K, Sugimoto T, Kaji H, et al. Stimulatory effect of growth hormone on bone resorption and osteoclast differentiation. Endocrinology 1996;137(1):35-41.
37. Mochizuki H, Hakeda Y, Wakatsuki N, et al. Insulin-like growth factor-I supports formation and activation of osteoclasts. Endocrinology 1992;131(3):1075-1080.
38. Hill PA, Reynolds JJ, Meikle MC. Osteoblasts mediate insulin-like growth factor-I and -II stimulation of osteoclast formation and function. Endocrinology 1995;136(1):124-131.
39. Brighton CT, Morphology and biochemistry of the growth plate. Rheum Dis Clin North Am 1987;13:75-100.
40. Horton WA. The biology of bone growth. Growth Genet Horm 1990;6:1-5.
41. Isgaard J. Expression and regulation of IGF-I in cartilage and skeletal muscle. Growth Regul 1992;2:16-22.
42. Saggese G, Federico G, Cinquanta L. In vitro effects of growth hormone and other hormones on chondrocytes and osteoblast-like cells. Acta Paediatr Suppl 1993;391:54-59.
43. Vetter U, Zapf J, Heit W, et al. Human fetal and adult chondrocytes: Effect of insulin-like growth factors I and II, insulin, and growth hormone on clonal growth. J Clinical Invest 1986;77:1903-1908.
44. Schlecter NL, Russell SM, Spencer EM, et al. Evidence suggesting that the growth-promoting effect of growth hormone on cartilage in vivo is mediated by local production of somatomedin. Proc Natl Acad Sci USA 1986;83:7932-7934.
45. Baroncelli GI, Bertelloni S, Ceccarelli C, et al. Measurement of volumetric bone mineral density accurately determines degree of lumbar undermineralization in children with growth hormone deficiency. J Clin Endocrinol Metab 1998;83(9):3150-3154.
46. Saggese G, Baroncelli GI, Bertelloni S, et al. The effect of long-term growth hormone (GH) treatment on bone mineral density in children with GH deficiency. Role of GH in the attainment of peak bone mass. J Clin Endocrinol Metab 1996;81(8):3077-3083.
47. Finkelstein JS, Klibanski A, Neer RM. Evaluation of lumber spine bone mineral density (BMD) using dual energy X-ray absorptiometry (DXA) in 21 young men with histories of constitutionally-delayed puberty. J Clin Endocrinol Metab 1999;84(9): 3400-3401.
48. Bachrach LK, Katzman DK, Litt IF, et al. Recovery from osteopenia in adolescent girls with anorexia nervosa. J Clin Endocrinol Metab 1991;72(3):602-606.
49. Murray RD, Darzy KH, Gleeson HK, et al. GH-deficient survivors of childhood cancer: GH replacement during adult life. J Clin Endocrinol Metab 2002;87(1):129-135.
50. Bachrach LK, Hastie T, Wang MC, et al. Bone mineral acquisition in healthy Asian, Hispanic, black, and Caucasian youth: A longitudinal study. J Clin Endocrinol Metab 1999;84(12): 4702-4712.